This session focuses on cancer biology research, including molecular mechanisms of carcinogenesis, tumor microenvironment interactions, and therapeutic strategies. Discussions will cover targeted therapies, immunotherapy approaches, and personalized treatment options based on molecular profiling. Cancer remains a leading cause of mortality worldwide, necessitating continuous research efforts to understand disease progression and develop effective treatments. By discussing cancer biology advancements and clinical trials outcomes, this session aims to advance cancer research, improve survival rates, and promote collaboration among oncologists, researchers, and pharmaceutical companies in the fight against cancer.